Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1085628.RAUXAe8BtkE3fi5HQp3idYEh5QYQ5l2txUYSZCl1ho6W4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1085628.RAUXAe8BtkE3fi5HQp3idYEh5QYQ5l2txUYSZCl1ho6W4130_assertion type Assertion NP1085628.RAUXAe8BtkE3fi5HQp3idYEh5QYQ5l2txUYSZCl1ho6W4130_head.
- NP1085628.RAUXAe8BtkE3fi5HQp3idYEh5QYQ5l2txUYSZCl1ho6W4130_assertion description "[Medications which target specifically the ACE2/Ang-(1-7)/Mas axis may offer new therapeutic opportunities to treat human nephropathies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1085628.RAUXAe8BtkE3fi5HQp3idYEh5QYQ5l2txUYSZCl1ho6W4130_provenance.
- NP1085628.RAUXAe8BtkE3fi5HQp3idYEh5QYQ5l2txUYSZCl1ho6W4130_assertion evidence source_evidence_literature NP1085628.RAUXAe8BtkE3fi5HQp3idYEh5QYQ5l2txUYSZCl1ho6W4130_provenance.
- NP1085628.RAUXAe8BtkE3fi5HQp3idYEh5QYQ5l2txUYSZCl1ho6W4130_assertion SIO_000772 23762470 NP1085628.RAUXAe8BtkE3fi5HQp3idYEh5QYQ5l2txUYSZCl1ho6W4130_provenance.
- NP1085628.RAUXAe8BtkE3fi5HQp3idYEh5QYQ5l2txUYSZCl1ho6W4130_assertion wasDerivedFrom befree-2016 NP1085628.RAUXAe8BtkE3fi5HQp3idYEh5QYQ5l2txUYSZCl1ho6W4130_provenance.
- NP1085628.RAUXAe8BtkE3fi5HQp3idYEh5QYQ5l2txUYSZCl1ho6W4130_assertion wasGeneratedBy ECO_0000203 NP1085628.RAUXAe8BtkE3fi5HQp3idYEh5QYQ5l2txUYSZCl1ho6W4130_provenance.